10th, June 2016 PROALT has been selected by Enterprise Europe Network (EEN) as a successfully funded company and invited to present its ColoDetect project in the European Commission's booth #5977 at BIO International Convention trade fair. The event, hold in San Francisco (United States), took place on Wednesday 8 June 2016. PROALT presented the key [...]
1st, April 2016 ColoDetect project announces the launch of its website. ColoDetect is a project funded by the European Union through the H2020 SME Instrument Phase 2 and developed by Protein Alternatives (PROALT). The project started in October 2015 and will run for three years. Its objective is the development and commercialization of a blood-based [...]
October 1st, 2015 COLODETECT, a proposal submitted by the Spanish biotechnology company PROALT, has been selected to receive EU funding from H2020 SME Instrument. In total, the Commission received 580 project proposals from European SMEs by the first cut-off date of the so-called Horizon 2020’s SME Instrument Phase 2. PROALT is the only Spanish company [...]
18th, June 2015 PROALT has participated in BIO International Convention 2015. This year's event has been held from 15 to 18 June 2015 in Philadelphia (United States). The Spanish Pavillion was organized by ICEX (Spain Trade and Investment) and The Spanish Trade Commission in Chicago, and brought together other 52 companies and Spanish biotech institutions. [...]
May 6th, 2015 The 'Innovators' supplement of the 'El Mundo' newspaper, one of the most widely distributed journals in Spain, has interviewed Dr Juan Ignacio Imbaud, R&D Director of the biotech company Protein Alternatives (Madrid, Spain). The reason was the recent approval of the project named COLODETECT, which was presented by the company to the [...]
January 10th, 2015 Protein Alternatives' project proposal named 'ColoDetect - Development of a novel blood-based diagnostic test for colorectal cancer' has been selected to receive funding from the EU Framework Programme Horizon 2020 SME Instrument. The official communication was received by the company in December and the firm is negotiating the grant conditions at the [...]
October 10th, 2014Protein Alternatives has been finalist in 'The South Summit' 2014. The company was selected within the 100 finalists from more than 3000 startups from Southern Europe and South America, and participated in the new global start up hub event THE SOUTH SUMMIT 2014 on October 8-10. COLODETECT, un proyecto presentado por la empresa [...]
Human RPL37A (60S ribosomal protein L37a) recombinant protein
€150,00 – €2.820,00
Human SPRY1 (Protein sprouty homolog 1) recombinant protein
€150,00 – €2.820,00
Human DCTPP1 (dCTP pyrophosphatase 1) recombinant protein
€150,00 – €2.820,00
Copyright ©2020 Protein Alternatives SL. All rights reserved | Legal Notice & Privacy Policy
